Association of ITGB3 Gene Polymorphisms with the Risk of Developing Fetal Growth Restriction Syndrome |Biomedgrid

Fetal Growth Restriction (FGR) syndrome is an urgent problem of obstetric healthcare practice worldwide, causing perinatal morbidity and mortality, the risk of sudden infant mortality [1]. According to statistics provided by the World Health Organization, the number of newborns with fetal growth restriction syndrome in the countries of Central Asia ranges from 31.1%. In the United States, FGR is observed in 10-15% of births, with signs of perinatal hypoxia observed in 30% of children diagnosed with FGR.